What causes it at the cellular level
6, 2023 from Cooper D
La hiptesis propone que estas bacterias podran modular la microbiota intestinal, reducir la inflamacin de bajo grado y potencialmente estimular las clulas enteroendocrinas para aumentar la produccin de GLP-1 endgeno, posiblemente a travs de cidos grasos de cadena corta o sealizacin de cidos biliares
1 In the Surpass-Early trial, nearly 800 adults diagnosed with type 2 diabetes within the past four years were assigned to add either tirzepatide, sold as 1 Most patients in the control group received other GLP-1 drugs including semaglutide, sold by Novo Nordisk as Ozempic and Rybelsus, or Lilly's own dulaglutide
Arnott C, Li Q, Kang A, Neuen BL, Bompoint S, Lam CSP, Rodgers A, Mahaffey KW, Cannon CP, Perkovic V, et al